RejuvStem Announced New Stem Cell Lab in Miami
The company will open a manufacturing facility near Miami to supply clinics with stem cell treatments.
Updated on Oct. 7, 2026 in Arthritis
Live Poll
Do you support the expansion of domestic stem cell manufacturing facilities in the United States?
RejuvStem is expanding its operations by launching a new stem cell manufacturing lab near Miami. This facility is expected to open within one to two months to support partner clinics across the region.
Why it matters
The expansion is supported by Florida’s state-level regulatory framework, which allows for the growth of stem cell therapies. The lab will provide materials for treatments currently being offered by the company to address conditions like chronic pain.
One in four American adults currently report living with chronic pain. The company produces stem cells derived from donated placental tissue collected following elective C-section deliveries.
The players
RejuvStem
This biotechnology company focuses on producing stem cells derived from donated placental tissue for medical treatments.
John Merola
He serves as the chief operating officer and is a partner at RejuvStem.
Chirag Shah
He is the founder of RejuvStem and established the company five years ago.
The details
The new lab will process and distribute stem cells to partner clinics throughout Florida, Georgia, and Tennessee. These facilities offer treatments such as the DeZawa Muse cell therapy and Regenerator technology.
Timeline
Five years ago: Chirag Shah founded RejuvStem.
Two years ago: The company consolidated its clinical operations in Cancun.
Next one to two months: The Miami lab is expected to open.
The Big Picture
This development follows Florida’s state-level regulatory framework for stem cell therapies, which enables clinical expansion within the region. The move aligns with the company's strategy to scale operations while adhering to specific state-level medical guidelines.
The new lab will increase the availability of specialized cell treatments for partner clinics across Florida, Georgia, and Tennessee. Patients seeking these therapies may find improved access to services once the facility begins operations in the coming months.
The takeaway
Advancements in biotechnology manufacturing reflect a growing industry effort to streamline the distribution of regenerative therapies to clinical settings. Patients should consult with licensed medical providers to discuss how these emerging treatments fit into their personal care plans.
Further reading
Learn more about the latest innovations in Arthritis treatments and care.
Source note: This article includes information reported by Medical Daily.
Live Poll
Do you support the expansion of domestic stem cell manufacturing facilities in the United States?
